N30 PHARMACEUTICALS INC has a total of 37 patent applications. Its first patent ever was published in 2009. It filed its patents most often in United States, EPO (European Patent Office) and Brazil. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are FREYNE EDDY JEAN EDGARD, N30 PHARMACEUTICALS LLC and ANNJI PHARM CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 16 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | Brazil | 3 | |
#4 | Republic of Korea | 3 | |
#5 | South Africa | 3 | |
#6 | Canada | 2 | |
#7 | Hong Kong | 2 | |
#8 | Israel | 1 | |
#9 | India | 1 | |
#10 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds | |
#5 | Microorganisms | |
#6 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Sun Xicheng | 34 |
#2 | Qiu Jian | 32 |
#3 | Wasley Jan | 13 |
#4 | Stout Adam | 12 |
#5 | Rosenthal Gary J | 11 |
#6 | Strong Sarah | 10 |
#7 | Jian Qiu | 1 |
#8 | Xicheng Sun | 1 |
#9 | Gary J Rosenthal | 1 |
#10 | Sarah Strong | 1 |
Publication | Filing date | Title |
---|---|---|
WO2014186704A2 | Novel compounds for the treatment of cystic fibrosis | |
EP2512247A1 | Novel thiophene inhibitors of s-nitrosoglutathione reductase | |
EP2618666A1 | Novel dihydropyrimidin-2(1h)-one compounds as neurokinin-3 receptor antagonists | |
EP2533637A1 | Chromone inhibitors of s-nitrosoglutathione reductase |